Jacobson Pharma Corporation Limited (2633.HK)
HKD 1.21
(-0.82%)
HKD 1.21
(-0.82%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 337.44 Million HKD | -40.03% |
| 2022 | 562.64 Million HKD | -39.58% |
| 2021 | 931.28 Million HKD | -20.29% |
| 2020 | 1.16 Billion HKD | -5.03% |
| 2019 | 1.23 Billion HKD | 84.31% |
| 2018 | 667.42 Million HKD | -3.98% |
| 2017 | 695.08 Million HKD | 20.19% |
| 2016 | 578.32 Million HKD | 61.71% |
| 2015 | 357.62 Million HKD | -12.45% |
| 2014 | 408.48 Million HKD | 131.86% |
| 2013 | 176.17 Million HKD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q2 | 451.86 Million HKD | 0.0% |
| 2023 FY | 337.44 Million HKD | -40.03% |
| 2023 Q4 | 337.44 Million HKD | 0.0% |
| 2022 Q4 | 562.64 Million HKD | 0.0% |
| 2022 FY | 562.64 Million HKD | -39.58% |
| 2022 Q2 | 696.91 Million HKD | 0.0% |
| 2021 FY | 931.28 Million HKD | -20.29% |
| 2021 Q4 | 931.28 Million HKD | 0.0% |
| 2021 Q2 | 876.8 Million HKD | 0.0% |
| 2020 Q4 | 1.16 Billion HKD | 0.0% |
| 2020 FY | 1.16 Billion HKD | -5.03% |
| 2020 Q2 | 1.16 Billion HKD | 0.0% |
| 2019 Q4 | 1.23 Billion HKD | 0.0% |
| 2019 FY | 1.23 Billion HKD | 84.31% |
| 2019 Q2 | 839.88 Million HKD | 0.0% |
| 2018 Q4 | 667.42 Million HKD | 0.0% |
| 2018 Q2 | 485.11 Million HKD | 0.0% |
| 2018 FY | 667.42 Million HKD | -3.98% |
| 2017 Q2 | 623.25 Million HKD | 0.0% |
| 2017 FY | 695.08 Million HKD | 20.19% |
| 2017 Q4 | 695.08 Million HKD | 0.0% |
| 2016 Q2 | -54.81 Million HKD | 0.0% |
| 2016 FY | 578.32 Million HKD | 61.71% |
| 2016 Q4 | 578.32 Million HKD | 0.0% |
| 2015 FY | 357.62 Million HKD | -12.45% |
| 2015 Q4 | 357.62 Million HKD | 0.0% |
| 2014 FY | 408.48 Million HKD | 131.86% |
| 2014 Q4 | -70.25 Million HKD | 0.0% |
| 2013 FY | 176.17 Million HKD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | -258.7 Million HKD | 230.436% |
| Grand Pharmaceutical Group Limited | 2.03 Billion HKD | 83.392% |
| Extrawell Pharmaceutical Holdings Limited | 5.94 Million HKD | -5577.019% |
| Wai Yuen Tong Medicine Holdings Limited | 301.53 Million HKD | -11.908% |
| Qianhai Health Holdings Limited | -19.03 Million HKD | 1872.466% |
| Lee's Pharmaceutical Holdings Limited | 30.94 Million HKD | -990.352% |
| Essex Bio-Technology Limited | -219.22 Million HKD | 253.922% |
| Tongfang Kontafarma Holdings Limited | 256.16 Million HKD | -31.729% |
| PuraPharm Corporation Limited | 377.54 Million HKD | 10.623% |
| SSY Group Limited | 1.71 Billion HKD | 80.307% |
| JBM (Healthcare) Limited | -7.39 Million HKD | 4660.643% |
| China Resources Pharmaceutical Group Limited | 50.97 Billion HKD | 99.338% |